Fenretinide in Healthy Young Women at Genetic and Familial Risk

Mise à jour : Il y a 4 ans
Référence : NCT01479192

Femme Homme

  • | Pays :
  • Italy
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this trial is to assess the effect of fenretinide (4-HPR), a vitamin A derivative, in reducing the incidence of breast cancer in healthy premenopausal women at increased familial/genetic risk for breast cancer


Critère d'inclusion

  • High-Risk Cancer

Liens